0001562180-23-006837.txt : 20230913 0001562180-23-006837.hdr.sgml : 20230913 20230913160134 ACCESSION NUMBER: 0001562180-23-006837 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230911 FILED AS OF DATE: 20230913 DATE AS OF CHANGE: 20230913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cardama Alfonso Quintas CENTRAL INDEX KEY: 0001760104 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39634 FILM NUMBER: 231252649 MAIL ADDRESS: STREET 1: C/O TCR2 THERAPEUTICS INC. STREET 2: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foghorn Therapeutics Inc. CENTRAL INDEX KEY: 0001822462 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-586-3100 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2023-09-11 false 0001822462 Foghorn Therapeutics Inc. FHTX 0001760104 Cardama Alfonso Quintas 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 false true false false Chief Medical Officer false Stock Options (Right to buy) 7.57 2023-09-11 4 A false 272000.00 7.57 A 2033-09-10 Common Stock 272000.00 272000.00 D The option vests as to 25% of the underlying shares of common stock on September 11, 2024, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested. /s /Allan Reine, M.D., Attorney-in-Fact 2023-09-13